The amino terminal and E2F interaction domains are critical for C/EBPα-mediated induction of granulopoietic development of hematopoietic cells
- 1 November 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (9) , 3163-3171
- https://doi.org/10.1182/blood-2003-02-0479
Abstract
The transcription factor C/EBPα (CCAAT/enhancer binding protein α) is critical for granulopoiesis. Gene disruption in mice blocks early granulocyte differentiation and disruption of C/EBPα function has been implicated in human acute myeloid leukemia (AML), but no systematic structure-function analysis has been undertaken to identify the mechanisms involved in C/EBPα-mediated granulocyte differentiation. Here we demonstrate that loss of either of 2 key regions results in disruption of C/EBPα granulocytic development: the amino terminus and specific residues residing on the non-DNA binding face of the basic region. Mutation of either results in loss of C/EBPα inhibition of E2F and down-regulation of c-Myc, but only mutation of the basic region results in loss of physical interaction with E2F. In contrast, while the amino terminal mutant retains the ability to interact with E2F, this mutant fails to bind a C/EBPα site efficiently, fails to activate C/EBPα target genes, and is also defective in inhibition of E2F activity. These results further emphasize the importance of inhibition of proliferative pathways in granulopoiesis and demonstrate that several regions of the C/EBPα protein are involved in this mechanism.Keywords
This publication has 48 references indexed in Scilit:
- Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)Blood, 2002
- Myeloid or Lymphoid Promiscuity as a Critical Step in Hematopoietic Lineage CommitmentDevelopmental Cell, 2002
- Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemiasBlood, 2002
- AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemiaNature Medicine, 2001
- Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemiaNature Genetics, 2001
- C/EBP Bypasses Granulocyte Colony-Stimulating Factor Signals to Rapidly Induce PU.1 Gene Expression, Stimulate Granulocytic Differentiation, and Limit Proliferation in 32D cl3 MyeloblastsBlood, 1999
- CCAAT/Enhancer Binding Protein α Is a Regulatory Switch Sufficient for Induction of Granulocytic Development from Bipotential Myeloid ProgenitorsMolecular and Cellular Biology, 1998
- Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient miceProceedings of the National Academy of Sciences, 1997
- A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cellsBlood, 1992
- The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding ProteinsScience, 1988